SensyTouch Partners with GlaxoSmithKline for Multi-touch Presentation Application

• 

Pharmaceutical and healthcare companies are where multi-touch solutions provide a powerful tool.” Suda Sampath, SensyTouch President & CEO.

Irvine, CA (PRWEB) October 25, 2012

SensyTouch, developers of premium multi-touch solutions, has joined forces this month with GlaxoSmithKline(GSK), one of the world’s leading research-based pharmaceutical and healthcare companies.

Under the partnership, SensyTouch has created multi-touch presentation application for three of GSK’s products—VOTRIENT, TYVERB and HYCAMTIN. GSK plans to use the SensyTouch multi-touch solution to present its three pharmaceutical products at various industry trade shows and events.

GSK will utilize the SensyTouch 42” (ST42MT) multi-touch table supporting 32 simultaneous zero-pressure touches.

“This is one of SensyTouch’s many strengths—the ability to bring responsive, fast interaction to a multitude of industries to help engage customers and audiences,” said SensyTouch President and CEO - Suda Sampath.

The multi-touch application created for GSK by SensyTouch is designed to reveal the action mechanisms of the active substances contained in each group of drugs and the risk combination with other drugs or clinical symptoms that may occur.    

To make an appointment to visit the SensyTouch showroom, call +1 (877) 396-9676 or email info@sensytouch.com

SensyTouch develops, engineers and markets a premium range of multi-touch solutions, featuring slender, elegant design, responsive, fast interaction for a limitless number of industries that want to improve the way they do business.

PDF Print